# US 8,569,503 B2 · Processes and intermediates for preparing fused heterocyclic kinase inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,569,503 B2
- Document ID: US8569503B2
- Status: Granted
- Kind: B2
- Application number: 13/330,959
- Filed: 2011-12-20
- Published: 2012-04-19
- Granted: 2013-10-29
- Earliest claimed: 2007-08-29
- Assignees: MethylGene Inc.
- Applicants: Ljubomir Isakovic
- Inventors: Ljubomir Isakovic
- Web page: https://patentgrep.com/patent/US8569503B2

## CPC

- C07D 495/04: Ortho-condensed systems
- C07D 213/38: having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
- C07D 213/51: Acetal radicals
- C07D 213/61: Halogen atoms or nitro radicals
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

This invention relates to processes and intermediates for manufacturing fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, and to processes and intermediates for preparing intermediates that are useful in the manufacture of fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, particularly at an industrial level.

## Claims

### Claim 1

A compound having the structure: